Systemic inflammation after critical illness: Relationship with physical recovery and exploration of potential mechanisms

Thorax

Volumn 71, Issue 9, 2016, Pages 820-829

  Griffith, David M ^a,b,c   Lewis, Steff ^d   Rossi, Adriano G ^b   Rennie, Jillian ^b   Salisbury, Lisa ^d   Merriweather, Judith L ^c   Templeton, Kate ^c   Walsh, Timothy S ^a,b,c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Assisted Ventilation; Exercise; Innate Immunity

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOCYTE ELASTASE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1; VIRUS DNA; AUTACOID; BIOLOGICAL MARKER;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; COMORBIDITY; CONTROLLED STUDY; CONVALESCENCE; CRITICAL ILLNESS; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATHOGENESIS; PATIENT MOBILITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RIVERMEAD MOBILITY INDEX; AGED; BLOOD; CLINICAL TRIAL; COMPLICATION; CYTOMEGALOVIRUS; FOLLOW UP; ISOLATION AND PURIFICATION; LENGTH OF STAY; METABOLISM; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICS AND NUMERICAL DATA; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VIROLOGY;

ADULT; AGED; BIOMARKERS; C-REACTIVE PROTEIN; CRITICAL ILLNESS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION MEDIATORS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; RECOVERY OF FUNCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84965031273     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2015-208114     Document Type: Article

References (47)

1. Herridge MS, Tansey CM, Matté A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 2011;364:1293-304.
2. Stevens RD, Marshall SA, Cornblath DR, et al. A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med 2009;37: S299-308.
3. Hund E. Myopathy in critically ill patients. Crit Care Med 1999;27:2544-7.
4. Puthucheary ZA, Rawal J, McPhail M, et al. Acute skeletal muscle wasting in critical illness. Jama 2013;310:1591-600.
5. Fan E, Cheek F, Chlan L, et al. An official American Thoracic Society Clinical Practice guideline: the diagnosis of intensive care unit-acquired weakness in adults. Am J Respir Crit Care Med 2014;190:1437-46.
6. Connolly B, Salisbury L, O'Neill B, et al. Exercise rehabilitation following intensive care unit discharge for recovery from critical illness. In: The Cochrane Collaboration, ed. Cochrane database of systematic reviews. Chichester, UK: John Wiley & Sons, Ltd, 2015. http://doi.wiley.com/10.1002/14651858.CD008632.pub2 (accessed 12 Nov 2015).
7. Walsh TS, Salisbury LG, Merriweather JL, et al. Increased Hospital-Based Physical Rehabilitation and Information Provision After Intensive Care Unit Discharge: The RECOVER Randomized Clinical Trial. JAMA Intern Med 2015;175: 901-10.
8. Kress JP, Hall JB. ICU-acquired weakness and recovery from critical illness. N Engl J Med 2014;370:1626-35.
9. Eid AA, Ionescu AA, Nixon LS, et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1414-18.
10. Raj DSC, Shah H, Shah VO, et al. Markers of inflammation, proteolysis, and apoptosis in ESRD. Am J Kidney Dis 2003;42:1212-20.
11. Roubenoff R, Parise H, Payette HA, et al. Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am J Med 2003;115:429-35.
12. Toth MJ, Ades PA, Tischler MD, et al. Immune activation is associated with reduced skeletal muscle mass and physical function in chronic heart failure. Int J Cardiol 2006;109:179-87.
13. Griffith DM, Vale ME, Campbell C, et al. Persistent inflammation and recovery after intensive care: a systematic review. J Crit Care Published Online First: 13 Jan 2016. doi:10.1016/j.jcrc.2016.01.011
14. Heininger A, Haeberle H, Fischer I, et al. Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis. Crit Care 2011;15:R77.
15. Heininger A, Jahn G, Engel C, et al. Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care Med 2001; 29:541-7.
16. Limaye AP, Kirby KA, Rubenfeld GD, et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 2008;300:413-22.
17. Cook CH, Martin LC, Yenchar JK, et al. Occult herpes family viral infections are endemic in critically ill surgical patients. Crit Care Med 2003;31: 1923-9.
18. Jaber S, Chanques G, Borry J, et al. Cytomegalovirus infection in critically ill patients: associated factors and consequences. Chest 2005;127:233-41.
19. Chiche L, Forel JM, Roch A, et al. Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients. Crit Care Med 2009;37:1850-7.
20. Jackson SE, Mason GM, Wills MR. Human cytomegalovirus immunity and immune evasion. Virus Res 2011;157:151-60.
21. Van De Berg PJ, Heutinck KM, Raabe R, et al. Human cytomegalovirus induces systemic immune activation characterized by a type 1 cytokine signature. J Infect Dis 2010;202:690-9.
22. Walsh TS, Salisbury LG, Boyd J, et al. A randomised controlled trial evaluating a rehabilitation complex intervention for patients following intensive care discharge: the RECOVER study. BMJ Open 2012;2. pii: e001475.
23. Ramsay P, Salisbury LG, Merriweather JL, et al. A rehabilitation intervention to promote physical recovery following intensive care: a detailed description of construct development, rationale and content together with proposed taxonomy to capture processes in a randomised controlled trial. Trials 2014;15:38.
24. Collen FM, Wade DT, Robb GF, et al. The Rivermead Mobility Index: a further development of the Rivermead Motor Assessment. Int Disabil Stud 1991;13: 50-4.
25. Massy-Westropp NM, Gill TK, Taylor AW, et al. Hand Grip Strength: age and gender stratified normative data in a population-based study. BMC Res Notes 2011;4:127.
26. Podsiadlo D, Richardson S. The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991;39:142-8.
27. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33.
28. Shine B, de Beer FC, Pepys MB. Solid phase radioimmunoassays for human C-reactive protein. Clin Chim Acta 1981;117:13-23.
29. Groll DL, Heyland DK, Caeser M, et al. Assessment of long-term physical function in acute respiratory distress syndrome (ARDS) patients: comparison of the Charlson Comorbidity Index and the Functional Comorbidity Index. Am J Phys Med Rehabil 2006;85:574-81.
30. Sterne JAC, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009;338: b2393.
31. Mislevy RJ, Little RJA, Rubin DB. Review of statistical analysis with missing data. J Educ Stat 1991;16:150-5.
32. Wang Z, Chen F, Zhai R, et al. Plasma neutrophil elastase and elafin imbalance is associated with acute respiratory distress syndrome (ARDS) development. PLoS ONE 2009;4:e4380.
33. Antonelli A, Ferri C, Ferrari SM, et al. Serum levels of proinflammatory cytokines interleukin-1β, interleukin-6, and tumor necrosis factor α in mixed cryoglobulinemia. Arthritis Rheum 2009;60:3841-7.
34. Kobawala TP, Patel GH, Gajjar DR, et al. Clinical utility of serum interleukin-8 and interferon-alpha in thyroid Diseases. J Thyroid Res J Thyroid Res 2011; 2011: e270149.
35. Lin Y, Nakachi K, Ito Y, et al. Variations in serum transforming growth factor-β1 levels with gender, age and lifestyle factors of healthy Japanese adults. Dis Markers 2009;27:23-8.
36. Grobmyer SR, Barie PS, Nathan CF, et al. Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia. Crit Care Med 2000;28:1276-82.
37. Staras SA, Dollard SC, Radford KW, et al. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 2006;43: 1143-51.
38. Fan E, Dowdy DW, Colantuoni E, et al. Physical complications in acute lung injury survivors: a two-year longitudinal prospective study. Crit Care Med 2014;42:849-59.
39. Groll DL, To T, Bombardier C, et al. The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol 2005;58:595-602.
40. Bateman AP, McArdle F, Walsh TS. Time course of anemia during six months follow up following intensive care discharge and factors associated with impaired recovery of erythropoiesis. Crit Care Med 2009;37:1906-12.
41. Yende S, D'Angelo G, Kellum JA, et al. Inflammatory Markers at Hospital Discharge Predict Subsequent Mortality after Pneumonia and Sepsis. Am J Respir Crit Care Med 2008;177:1242-7.
42. Fong Y, Moldawer LL, Marano M, et al. Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. Am J Physiol 1989;256(Pt 2): R659-65.
43. Baracos V, Rodemann HP, Dinarello CA, et al. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med 1983;308:553-8.
44. Charters Y, Grimble RF. Effect of recombinant human tumour necrosis factor alpha on protein synthesis in liver, skeletal muscle and skin of rats. Biochem J 1989;258:493-7.
45. Miller SC, Ito H, Blau HM, et al. Tumor necrosis factor inhibits human myogenesis in vitro. Mol Cell Biol 1988;8:2295-301.
46. Zamir O, Hasselgren PO, James H, et al. Effect of tumor necrosis factor or interleukin-1 on muscle amino acid uptake and the role of glucocorticoids. Surg Gynecol Obstet 1993;177:27-32.
47. Connolly B, MacBean V, Crowley C, et al. Ultrasound for the assessment of peripheral skeletal muscle architecture in critical illness: a systematic review. Crit Care Med 2015;43:897-905.